Metformin {60000057}

Record Keys


Parent:[  ]
Definition:
Metformin
Queue:[  ]

Details


Initialisation date:
2020-09-21
Specification:

N,N-dimethylbiguanide

Source:
[  ]

Links


Meta Information


Structural Type:[  ]
Functional Type:[  ]
Function:[  ]

Notes:


- Lactate uptake by the liver is diminished with metformin use because lactate is a substrate for hepatic gluconeogenesis, a process that metformin inhibits.
- Metformin has been suggested as increasing production of lactate in the large intestine.
- Epidemiological studies first recognized a relationship with metformin use in T2DM patients and reduced colorectal cancer (CRC) risk. (2)

- metformin treatment significantly increase Escherichia coli and lowers Intestinibacter abundance.
- This effect is thought to be mediated by metformin’s effect on short-chain fatty acid (butyrate)-producing bacteria and the abundance of Akkermansia muciniphila, as well as through common biological pathways and genes encoded in different metformin-affected bacteria. (3)

-bcat-1 knockdown increases mitochondrial respiration and induces oxidative damage in neurons through mammalian target of rapamycin-independent mechanisms. Increased mitochondrial respiration, or "mitochondrial hyperactivity," is required for bcat-1(RNAi) neurotoxicity.
-Post-disease-onset administration of the type 2 diabetes medication metformin reduces mitochondrial respiration to control levels and significantly improves both motor function and neuronal viability.(4)

Shared Reference Notes


  • [1.1
    - metformin treatment, shifts a depletion of butyrate-producing taxa in T2D patient. These in turn cause functional microbiome shifts, in part alleviated by metformin-induced changes.
  • [1.2] [#Diabetes Type 2
    - The commonly used diabetes treatment Metformin increase #Akkermansia spp. abundance, and to significantly improve glucose metabolism in high-fat diet fed mice while also increasing the number of mucin-producing goblet cells.
  • [1.3] [#Diabetes Type 2
    - there is a negative association between specific species such as B. adolescentis, B. bifidum, B. pseudocatenulatum, B. longum, B. dentium and disease in patients treated with metformin or after undergoing #Gastric bypass surgery
  • [1.4] [#Oral administration of Metformin
    - Metformin, decreased leaky gut and inflammation in high-fat diet-fed older obese mice, by beneficially modulating the gut microbiota. - Metformin increased goblet cell mass and mucin production in the obese older gut, thereby decreasing leaky gut and inflammation. - Metformin treatment slightly increased Bacteroidetes in HFD-fed mice compared to their untreated HFD-fed counterparts. - The abundance of genera belonging to S24_7, Ruminococcaceae and Lactococcus were increased, while that of Coriobacteriaceae, Lactobacillus, Dorea, SMB53, Roseburia and Veilonellaceae, and Dehalobacterium was significantly decreased in the gut of metformin-treated HFD-fed older mice compared to their HFD-fed controls. - Similarly, the proportion of Clostridiales;g, Lachnospiraceae;g, and Ruminococcus was significantly increased while that of genus Sutterella was significantly decreased in metformin-treated LFD-fed mice compared to their LFD-fed counterparts. - The abundance of 5-aminopantanoate_1, propionate and butyrate was increased while that of 5-aminopentanoate_2, ethanol, sarcosine, formate, creatinine, propylene glycol, and several others were decreased in metformin-treated LFD-fed older mice compared to untreated LFD-fed controls. Similarly, the abundance of taurine, butyrate, total bile acids_1, propionate, and leucine was increased while that of creatinine, sarcosine, glutamate, pyruvate, and formate was significantly decreased in the feces of metformin-treated HFD-fed older mice compared to their untreated HFD-fed counterparts . Metformin caused highest increase in butyrate and taurine and highest decrease in creatinine and sarcosine abundance in the gut of older mice .
  • [1.5] [#Diabetes Type 2, #Parkinson’s Disease] [#Oral administration of Metformin
    - metformin reduces neuronal damage in the brains of PD patients via neuroprotection and the inhibition of oxidative stress and inflammatory responses, thus providing a novel strategy for the clinical treatment of PD.
  • [1.6] [#Parkinson’s Disease
    - metformin-mediated AMPK activation may reduce the level of neuronal loss and alleviate several phenotypes associated with these disorders. - a metformin therapy for more than 4 years significantly decreased the risk of developing both PD and AD.
  • [1.7] [#Diabetes Type 2] [#Oral administration of Metformin
    - #Faecalibacterium prausnitzii > significant decrease in patients with T2DM treated with metformin alone, while no significant decrease was observed in patients treated with metformin combined with #Benaglutide.
  • [1.8] [#Diabetes Type 2] [#Prevotella copri
    - Patients with T2D, especially those on metformin only (rather than metformin and glibenclamide), had a higher relative abundance of P. copri than healthy controls
  • [1.9] [#Bilophila wadsworthia] [#High Fat Diet
    - HFD-induced increase of (B. wadsworthia) which is bile-tolerant was further aggravated by #Silymarin/#Silibinin treatment. - B. wadsworthia was sensitive to the environmental redox changes as the abundance of this bacterium was also found largely increased in vitro upon exposure of metformin
  • - abundance of #Escherichia/#Shigella was found increased by both #Silymarin and metformin
  • [#β-blocker] - A total of 46 associations were identified between microbial composition and single medications, exemplified by the depletion of #Akkermansia muciniphila by β-blockers and #Statins, and the enrichment of #Escherichia/#Shigella and depletion of #Bacteroides xylanisolvens by metformin.
  • [#Statins] - depletion of #Romboutsia and #Butyriciocccus by statin plus metformin.
  • [1.11] [#Breast cancer, #Cancer] [#Keto diet
    - animals treated with the combination regimen showed significantly lower tumor burden, higher tumor latency and slower tumor growth. - lowering systemic #Glucose by this combined dietary and pharmacologic approach improved overall survival in our mouse model by 31 days, which is approximately equivalent to 3 human years.
  • [1.12] [#Short Chain Fatty Acid
    - adults with #Prediabetes > metformin > increased the abundance of GM SCFA-producing bacteria M (#Fusicatenibacter and #Blautia) - adults with #Prediabetes > linagliptin/metformin > Roseburia, Bifidobacterium, and [Eubacterium] hallii group.

References Notes


  • (1) [1.13
  • (3) [1.14

Common References


MetaBiom only uses strictly necessary session cookies to give you the best possible experience on the website. By selecting "Accept essential cookies" you agree to the use of these cookies.